(Total Views: 550)
Posted On: 09/01/2019 4:54:00 AM
Post# of 149011
Our combo market is huge ..
As we know in 2020 projected over 260k patients in USA with MDR2, so this is over 180 K CCR5 positive patients .after approval we will apply for Europe immediately according to Dr NP , this should be approve very quickly there , and Europe is twice big ,, and now add Asia , Africa , South and Central America.. this market is huge ..
It is hard to believe that Letonlimab will be approve for combo within 6 months ..This month BLA should be finished , but in the worse if we be one month late , approval will be 1Q of 2020 ,
after so many years I was waiting here it is finally hand reach !!!
IMO of course ..
As we know in 2020 projected over 260k patients in USA with MDR2, so this is over 180 K CCR5 positive patients .after approval we will apply for Europe immediately according to Dr NP , this should be approve very quickly there , and Europe is twice big ,, and now add Asia , Africa , South and Central America.. this market is huge ..
It is hard to believe that Letonlimab will be approve for combo within 6 months ..This month BLA should be finished , but in the worse if we be one month late , approval will be 1Q of 2020 ,
after so many years I was waiting here it is finally hand reach !!!
IMO of course ..
(1)
(0)Scroll down for more posts ▼
